[Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria].
A pediatric consensus report on allergen-specific immunotherapy for children and adolescents is presented for Austria. Products on the market in Austria are presented and categorised according to studies performed on the target population of children and adolescents, their effectiveness and indication. In general, more clinical studies on children and adolescents are mandatory for most of the available allergen-specific immunotherapeutics. In addition, the use of allergen-specific immunotherapy in general should be promoted as the exclusive treatment with long-lasting effects in type I allergies in particular in children.
Szépfalusi
Zsolt
Z
Univ.-Klinik für Kinder und Jugendheilkunde, Austria, zsolt.szepfalusi@meduniwien.ac.at
Emminger
Waltraud
W
Eitelberger
Franz
F
Götz
Manfred
M
Grillenberger
Andrea
A
Horak
Elisabeth
E
Huttegger
Isidor
I
Koller
Dieter
D
Litscher
Helmut
H
Schmitzberger
Rudolf
R
Varga
Eva-Maria
EM
Riedler
Josef
J
D000293:Adolescent; D000485:Allergens / Q000145:classification* / Q000627:therapeutic use*; D001317:Austria; D002648:Child; D002675:Child, Preschool; D003888:Desensitization, Immunologic / Q000379:methods* / Q000639:trends*; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D008297:Male
D000485:Allergens